Individual and combined effects of exercise training and dietary fat on myocardial triglycerides in obese mice by Cortez, Filand
  INDIVIDUAL AND COMBINED EFFECTS OF EXERCISE TRAINING
AND DIETARY FAT ON MYOCARDIAL TRIGLYCERIDES IN
       OBESE MICE
BY
FILAND TALAVERA CORTEZ
           THESIS
Submitted in partial fulfillment of the requirements
for the degree of Master of Science in Kinesiology
  in the Graduate College of the
University of Illinois in Urbana-Champaign, 2012
  Urbana, Illinois
Adviser:
Professor Kenneth Wilund
ii
ABSTRACT
Visceral adipose tissue has been suggested to have a stronger association with disease
than subcutaneous adipose tissue.  This is primarily due to its inflammatory nature.  Epicardial
adipose tissue is a type of visceral fat located on the exterior of the heart.  Recent evidence
suggests an association between atherosclerosis, epicardial fat, and hepatic triglyceride
deposition.  PURPOSE -The purpose of this study was to determine the individual and combined
effects of endurance exercise training and changes in dietary fat intake on myocardial
triglyceride, a marker of epicardial fat, as well as hepatic triglycerides, another visceral fat depot
implicated in CVD and diabetes risk, in a mouse model of dietary induced obesity.
METHODS – Male c57BL/6 mice (n=73) fed a 45% high-fat diet for 6-weeks to induce obesity
were randomly assigned into four groups: exercise high-fat, exercise low-fat, sedentary high-fat,
sedentary low-fat.  Exercise intervention consisted of treadmill running for 5 days/week, 40
min/day, at an intensity of 65-70% VO2  max for 12 weeks.  After the 12 weeks, animals were
sacrificed and both hearts and liver were removed.  Using a triglyceride assay, myocardial and
liver triglycerides levels were determined.
RESULTS – Exercise training significantly lowered liver triglycerides in both high fat and low
fat fed mice  (p < 0.001 for both groups).  However, dietary fat intake did not have a significant
effect on liver triglycerides within activity groups.  Exercise training also lowered myocardial
triglycerides in mice fed a high fat diet (p = 0.005), but had no effect on myocardial triglycerides
in mice fed a low fat diet.  By contrast, mice fed a low fat diet had significantly lower
myocardial triglycerides than high fat fed mice, regardless of activity group (p < 0.01 for both
groups).
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CONCLUSION – Exercise training can attenuate epicardial/myocardial and hepatic fat
accumulation in obese mice.  Low fat diets can decrease myocardial fat accumulation in obese
mice.
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1            CHAPTER 1:  INTRODUCTION
The prevalence of obesity continues to increase year after year.  As the number of
individuals with this disorder rises, so do the incidences of comorbidities such as cardiovascular
disease.   The impact of obesity on our society and economy has been devastating, and in light of
this, scientists have taken a keen interest in adipose tissue biology1.
Based on this research, adipose tissue is no longer viewed as a simple storage organ.  It is
now known to be a highly active tissue secreting adipokines and inflammatory cytokines, which
participate in the inflammatory response2.   In fact, studies have indicated that adipose tissue in
the obese reflect an inflammatory profile compared to those of lean individuals3.
In human adults, the body primarily has two types of adipose tissue: subcutaneous and
visceral adipose tissue.  Of the two, visceral adipose tissue has been shown to be more pro-
inflammatory and metabolically active.  Thus, increase visceral adipose tissue has been
correlated with many inflammatory diseases4 such as type-2 diabetes and atherosclerosis5.
In recent years, epicardial fat, a type visceral adipose tissue, has garnered significant
attention.  This is primarily due to its proximity to the heart as well as its inflammatory profile.
Several studies published have indicated a correlation between the amount of tissue and
atherosclerosis6,7.  Furthermore, disease severity has also been positively correlated with this
tissue8.
Seeing that obesity has a clear and unequivocal role in many disorders, much work has
been done to identify methods to decrease adiposity, specifically in visceral adiposity.  One
approach that has proven to be successful is exercise.  Unfortunately, studies looking at the effect
exercise on epicardial fat deposition are few in number9,10.
2As mentioned, obesity has reached pandemic proportions and most have attributed this to
the changes in diet throughout the decades as well as the general decline in physical activity most
people incur.  Therefore, exercise has been proposed as a method to reduce adiposity and
inflammation11,12.  Recent publications indicate that physical activity can help reduce epicardial
thickness9,10.  Thus, determining the effect of physical activity on epicardial fat deposition would
be of great importance to the public.
The objective of this project is to test the hypothesis that moderate exercise will result in
reductions in epicardial fat, as estimated by total triglyceride levels.   It is predicted that exercise
will cause a decrease in epicardial fat in diet-induced obese mice.
Purpose
As mentioned, obesity has reached pandemic proportions and most have attributed this to
the changes in diet throughout the decades as well as the general decline in physical activity most
incur.  Therefore, exercise has been proposed as a method to reduce adiposity and inflammation.
Evidence suggests that exercise has anti-inflammatory properties and recent publications indicate
that physical activity can help reduce epicardial thickness.  Thus, determining the effect of
physical on epicardial fat would be of great importance to the public.
The aim of this project is to explore the independent and combined effects of exercise
training and dietary fat intake on myocardial and hepatic fat accumulation and to determine if
changes in these are correlated with changes in total body weight.
1. We hypothesized that a 12-week exercise program will reduce epicardial and
hepatic fat accumulation, using triglyceride levels in these organs as a proxy for
visceral adiposity.
32. Furthermore, we hypothesize that the changes in epicardial and hepatic
fat will be correlated with overall weight loss
4CHAPTER 2:  LITERATURE REVIEW
The Obesity Pandemic
It has been well established that obesity has become a major concern, not just here in the
United States, but globally.   Recent years have seen a rapid escalation in the numbers of
overweight and obese around the world13.  According to the World Health Organization, there is
an estimated 1 billion overweight people globally.  Of these, around 300 million are said to be
obese14.  In Europe, estimates indicate that average numbers of obesity doubled from 1985 to
2005.  It is predicted that this will again double over the next four decades15.  Though data is
limited and fragmented from Latin America, the information reveals that obesity rates are over
20% in adults from Countries such as Brazil, Argentina, Peru, and Paraguay16.  The Asia-Pacific
region has also seen a rise in obesity rates, from 5% in India to 60% in Australia.  Even more
astonishing are the estimates assessed from China.  Though the obesity rates in that country
ranks lower than Australia, the increase in numbers from the past 20 years has been 400%17.
Obesity rates will continue to rise in this region as countries continue to develop economically,
especially in China and India.
As previously mentioned, obesity has become a major concern here in the United States.
One reason for this is due to the rapid increase in the prevalence of this disease.  This swift
increase began around the 1980’s.  Twenty years prior to that, only an increase of less than 2
percentage points of 15% was reported.  However, during the late 1980’s and into the early
1990’s, those numbers increased dramatically to 23%.  By 2000 those numbers again increased
to 31%, a doubling from 20 years prior18,19.  As worrying as this trend may be, the numbers seen
concerning childhood obesity are just as, or even more staggering.  In developed countries
around the world, childhood obesity has also become an epidemic.  In the United States alone,
5twenty five percent of children are overweight.  Eleven percent of these are considered obese and
seventy percent of these obese children will grow up as obese adults20,21,22.  In a survey performed
from 1988-1994, a doubling to 11% was seen when compared to the last survey performed from
1976-1980.  A subsequent survey performed from 1999-2000 reported a rise of 4% occurred in 5
years23.
Maybe the most pressing concerns are the comorbidities related to obesity. As the
pervasiveness of obesity widens, so will the incidence of obesity-related diseases. Obesity has
been associated with several diseases such as cardiovascular diseases, diabetes, Alzheimer’s
disease, and certain types of cancer. More recently, obesity has been connected to depression24,25,.
As of 2005, obesity reportedly accounted for 400,000 deaths per year and was second only to
tobacco related deaths26.  Linking the current trend in childhood obesity together with its known
comorbidities has led many to suggest that this generation will likely have shorter lifespan than
their parents.  If this prediction were to occur, it would be the first time it would have happened
in recorded history27,28.
 As the prevalence of obesity escalates, the burden it will impose on our health care
system will also intensify.  If obesity was prevented or curtailed, health care expenditure would
have been lowered by approximately $46 billion in 199029.  In 2001, the Surgeon General
reported that the annual medical expenditure indirectly related to obesity was $64 billion30.
Expense directly related to obesity, however, was claimed to have been $75 billion.  When
updated to 2003 numbers, the total costs of obesity (indirectly and directly) may have been as
high as $139 billion 31.
The scope by which obesity has negatively affected us is incredible.  Its impact on us
physically and emotionally has been debilitating and dully noted.  Less visible but increasingly
6important, however, has been its impact on society.  Unfortunately, with the ongoing trend, it
seems that this disease will cost us more than just our health and well-being.
Causes of obesity
Obesity can be defined as a condition in which excess fat accumulates in adipose tissue,
to the extent where health may be impaired32.  Though the cause of obesity is complex and multi-
factorial, it is understood that this condition results when energy intake far exceeds energy
expenditure through resting metabolism and physical activity33.   Contributing to the
development of this disease are certainly genetic factors.  However, social and cultural
environment, lifestyle choices, unhealthy dietary habits, and physical inactivity seem to have
major influence in the rising prevalence of obesity33,34.
As countries develop and populations become more affluent, certain transformations in
dietary patterns have been noticed35.  These changes include an increase in fat consumption
(including saturated fat), a rise in sugar intake, and a large increase in animal food consumption.
In addition to these, declines in complex carbohydrates, fruit, and vegetable intake have also
been noted35,36,37.
Socioeconomic factors can also increase the incidence of obesity.  Nutrient-poor and
energy-dense foods are often less expensive and more obtainable for poor groups.  This is in
stark contrast to more prosperous individuals who are able to afford, and therefore, consume
nutrient-rich and overall better quality food items.  Augmenting this predicament is the
inaccessibility of vendors of healthy food items as many of these are located in more affluent
areas38.
Though genetic factors by themselves seldom bring about obesity, the interaction of
environment and genetic predisposition has sparked the interest in recent years. Gene-
7environment interaction refers to a situation in which the response or the adaptation to an
environmental agent, a behavior, or a change in behavior is conditional on the genotype of the
individual39. For instance, a study of healthy Japanese men indicated that a missense variant in
the interleukin 6 (IL-6) receptor gene interacted significantly with dietary energy intake levels in
relation to the risk of abdominal obesity40.
Aside from food consumption and genetics, the decline of physical activity has also
played a role in escalation of obesity.  Due to the aid of technology and jobs entailing less
physical activity, more and more have adopted an increasingly sedentary lifestyle41.  Inactivity
can lead to increased adiposity by reducing caloric expenditure as well as altering insulin and
leptin sensitivity42.
Several treatments for obesity exist and range in complexity from a change in dietary
habits to surgical interventions.  Though diet modification may be the simplest and least harmful
of the treatments, half of those that lose weight through diet alone will eventually regain all the
weight they had lost43.  Furthermore, similar reductions in fat are seen in those that combined
exercise and caloric restriction and those that incurred similar caloric deficits using diet alone.
Additionally, those that included exercise improved fitness, insulin resistance and diastolic blood
pressure44.  This indicates the beneficial effects of exercise in both weight loss and in other
biological markers that mark obesity related dysfunctions.
Inflammation
Inflammation is the physiological response an organism has to negative stimuli, be it
physical, chemical, or biological.  Response is a coordinated action of many cell types and
mediators in an attempt at regaining homeostasis45.  In a normal acute inflammatory response
(physical injury and infection) resident tissue macrophages and mast cells signal for the transport
8and migration of leukocytes to the site of the insult leading to the production of chemokines,
cytokines and other inflammatory mediators46.  If the response is successful, the agent is
eliminated and inflammation resolution and tissue repair commences.  In cases of long-term
infections or autoimmune diseases, inflammation can become chronic.  Response intensifies in
that cytokine levels can increase up to four times the levels of an acute response.  In addition,
this response also requires the recruitment of different mediators, specifically, T-
lymphocytes47,48.
Signature to the inflammatory response is the release and accumulation of cytokines and
macrophages.  Cytokines are proteins made by cells and affect the behavior of other cells49.
These proteins have a dual role in the inflammatory response. Cytokines signal the body to
increase defense mechanisms in the form of hematologic and immunologic responses50.
Furthermore, they induce the expression of genes and synthesize proteins that induce acute and
chronic inflammation.  In studies utilizing injury and endotoxins as a model for acute
inflammation, interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) are shown to
increase dramatically, especially immediately after the insult occurred50,51.  Similar results have
been seen in subjects with chronic inflammation.  As a matter of fact, elevated cytokine levels
have been associated with chronic conditions such as obesity, type-2 diabetes, and
atherosclerosis52,53,54.
As mentioned, macrophages play an integral role in inflammation.  During the
inflammatory response, macrophages become the first line of defense.  Recruited by chemokines,
these cells migrate to the site of the insult and secrete inflammatory proteins and phagocytose
pathogens or debris.  Macrophages can be activated in two ways: “classically” and
“alternatively”.  When classically activated, macrophages are triggered to destroy bacteria.  In
9this state, they are considered pro-inflammatory as they produce IL-1, IL-6, and TNF-α,
cytokines that are responsible for propagating the response55.  These macrophages are
“classically” activated when exposed to interferon gamma or lipopolysaccharides.  On the other
hand, when exposed to IL-4, IL-13, and transforming growth factor-beta (TGF-β), macrophages
produce proteins IL-10 and IL-1 receptor antagonists.  These proteins are anti-inflammatory, thus
lending to the term “alternatively” activated macrophages.  Because of their “classical” state,
macrophages have become a target for researchers investigating the mediators of inflammatory
diseases.  Consequently, macrophages have been associated with two of the most devastating
diseases of modern time –diabetes and cardiovascular disease56,57,58.  Other than through the
overproduction of pro-inflammatory cytokines, macrophages play an integral role in the onset
and propagation of atherosclerosis.  Macrophages, through the “scavenger-receptor” pathway,
internalize oxidized-LDL leading to the formation of cholesterol ester-laden foam cells, the
hallmark of atherosclerosis59,60.
The inflammatory response is the process by which an organism attempts to regain
homeostasis.  This is clearly meant to be beneficial; however, in cases where the response
becomes chronic, the response can become dangerous and assist in the onset and propagation of
diseases such as diabetes and heart disease.
Obesity and Inflammation
The main physiological role of adipocytes is to act as a storage depot for fat when energy
intake exceeds energy expenditure and to release free fatty acids when needed61.  Another
function of adipose tissue is its ability to aid in the inflammatory reponse62.  This occurs when
adipocytes in subcutaneous and visceral adipose tissues hypertrophy with triglyceride due to
obesity.  At this state, the adipocytes secrete numerous pro inflammatory cytokines such as TNF-
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α and macrophage chemoattractant protein-1 (MCP-1)63,64.  MCP-1 is a powerful chemokine that
attracts circulating monocytes and directs them to enter the expanding adipose depot and into the
non-adipocyte portion of the tissue termed the stromal-vascular matrix65.  These macrophages
then transform into activated M-1 macrophages66 and secrete even more MCP-1 to augment
monocyte recruitment.  These, along with an activated endothelium, generate other
proinflammatory cytokines such as interleukin-1 beta (IL-1β), IL-6, and interleuking-8 (IL-8)62,67.
These cytokines along with TNF-α autocrine feedback, inhibit insulin signaling in adipocytes68.
This results in insulin resistance and the transformation of stored triglycerides to free-fatty
acids68,69,70.  This causes M-2 activated macrophages to release the anti-inflammatory cytokine
interleukin-10 (IL-10) in an attempt to protect the adipocytes from the pro-inflammatory
molecules71.  Pro-inflammatory cytokines, especially IL-6 and TNF-α, inhibit adiponectin, a
modulator of fatty-acid catabolism72.  Both adipocytes and endothelium then produce VEGF73,
which causes angiogenesis to increase adipose tissue vascularity74.  The free-fatty acid
accumulation due to the decrease in adiponectin are then released from the adipose tissue into the
hepatic portal vein where they are used as substrates for the synthesis of atherogenic lipoprotein
B-containing VLDL-triglyceride particles.  These are then released into circulation75.
As insight into the nature of adipose tissue mounted, researchers sought to look at
whether differences can be spotted between the physiology lean and obese adipose tissues. As
mentioned above, obesity is a condition where excess fat accumulates in adipose tissue.
However, the amount of adipose tissue is not the only characteristic that is differentiates from its
lean counterpart.  Much work has been done to show that obese adipose tissue is physiologically
different than lean adipose tissue.  An important distinction between the two is the considerable
increase in inflammatory cytokines and acute phase reactants seen in obese adipose tissue. Xu
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and colleagues3 revealed a significant increase in MCP-1, TNFα, and macrophage infiltration in
adipose tissue of obese mice when compared to lean animals.  Several studies on humans
revealed similar results.  In a study using Japanese men, inflammatory markers were analyzed
and compared between individuals characterized with and without abdominal obesity.  Results
from this study indicated an increase in CRP and IL-6 in those with abdominal obesity as well as
an inverse relationship in adiponectin76  The decrease in adiponectin is quite important as this
protein is anti-inflammatory76,77 as well as anti-atherogenic78.
 Hotamisligil et al.54 produced a study yielded similar results.  Using tissues biopsies
taken from lean and obese pre-menopausal women, they illustrated that TNF-α mRNA
expression was markedly higher in the obese women compared to the age-matched lean controls.
Even more important than that result was their finding concerning TNF-α protein expression.
ELISA protein assays revealed that TNF-α protein expression was significantly higher in the
obese subjects compared to their age matched lean counterparts.
As stated earlier, macrophages are a key component of the inflammatory process,
especially in conditions characterized by chronic inflammation such as obesity.  Therefore,
ascertaining whether obese adipose tissue incurs greater macrophage infiltration is vital in
determining whether these tissues are more inflammatory. It was mentioned previously that
adipose tissue releases MCP-1 - a protein that attracts macrophages. Thus, Harman-Boehm et
al.79 investigated whether increased obesity had an effect on macrophage infiltration.  Results
from this study showed that MCP-1 mRNA and protein expression was greatly increased in
adipose tissue obtain from obese individuals.
A wonderful work by Weisberg et al.80, added to this ongoing trend.  This study utilized
both human and mouse models to identify and examine potential changes in inflammatory
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markers associated with obesity.  Additionally, these researchers looked at inflammation from
progression from lean to obese tissues by adding a third group (overweight) to the study. Several
types of adipose tissues (epididymal, perirenal, mesenteric, and inguinal subcutaneous) were
collected and analyzed from both mice and humans and the results once again yielded findings
similar to the others mentioned previously. Immunohistochemical assays performed on both
human and mouse adipose tissue revealed a positive correlation between macrophage infiltration,
adipocyte size, and increased adiposity.
Many other studies examining the pathophysiology of adipose tissue have been
performed.  Works investigating changes in inflammation from weight loss due to bariatric
surgery54,81 and other forms of weight loss reveal results like that of the studies detailed above,
that obese adipose tissue contain more markers of inflammation than their lean counterparts.
Moreover, further inspection of the data also reveals an important distinction between
adipose tissues.  However, the variation is not between lean and obese tissues.  Instead, the
difference is between visceral and subcutaneous tissues.  Both works by Weisberg and Harman-
Boehm not only revealed a significant difference in inflammatory markers between obese and
lean tissues, they also revealed that visceral fat had a marked increase in inflammatory cytokines
when compared to subcutaneous adipose tissue.  In accordance to these results, findings from a
study by Fein et al.82 found that both IL-6 and VEGF were significantly higher in visceral
adipose tissue compared to subcutaneous fat.  More support for this came from Zha et al.83 in
which they revealed a greater increase in TNFα gene expression in visceral adipose tissue
(compared to subcutaneous fat) in obese humans.  These findings indicate that visceral adiposity
may be a more important risk factor than total body fat in diseases thought to be inflammatory
related.
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Obesity, inflammation and disease
 The fact that obesity greatly increases an individual’s risk for disease has been
established for quite some time.  However, the mechanism by which this occurs still remains
indefinable.  Within the last two decades, the term “metabolic syndrome”, formerly known as
“syndrome X”, was created to describe a clustering of metabolic disorders that include insulin
resistance, central obesity, hypertension, dislipidemia, and hypertriglyceridemia84.  Thus, it has
been proposed that metabolic syndrome is what predisposes obese individuals to co-morbidities
such as the development of atherosclerosis, coronary heart disease events85, and diabetes86.
A component of metabolic syndrome, inflammation, has garnered much attention in
recent years.  As stated above, there is a difference in the physiology between obese and non-
obese adipose tissue.  Over a decade ago, it was discovered that obese adipose tissue in mice
expressed higher levels of TNF-α54 and that this was associated with impairments in insulin
function87.  Uysal et al.88 yielded similar results in showing that obese mice deficient in TNF-α or
its receptors improved insulin sensitivity. Support for this came from results showing improved
glucose tolerance in animals with the neutralization of TNFα89.
Other proinflammatory cytokines have also been associated with insulin resistance and
diabetes.  Insulin tolerance testing revealed that IL-1α deficient mice have greater insulin
sensitivity and lower fasting levels of both glucose and insulin when compared to wild type
animals.  IL-6 has also been linked with the onset/progression of diabetes.   This was shown in
patients that have undergone bariatric surgery whose improvement in insulin sensitivity was
associated with a decline in this cytokine90.  As the prevalence of diabetes continues to increase
dramatically, much work has been performed to linking insulin resistance and obesity, especially
since this condition is critical in the development of the type-II diabetes91.
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Just as inflammation has been implicated in the development of Type II Diabetes, work
has been done to show its relationship with and cardiovascular events92,93.  Utilizing data from
the Framingham Heart Study, Vasan et al.166 associated IL-6 with an increased risk of congestive
heart failure.  Results from a prospective study performed by Ridker et al.94 confirm the previous
finding.  Using healthy men as subjects, IL-6 was again shown to be predictive of cardiac
events95.   TNFα also has been linked to cardiovascular anomalies.  After analysis of data
obtained from the HEALTH Study, Cesari et al.96 produced results indicating at a very strong
relationship between TNFα and congestive heart failure (CHF).  They also claim that this
cytokine along with IL-6 may be a better predictor (of CVD) than CRP.  However, it must be
noted that the association between CRP and CVD decreases with age, and this project included
more elderly when compared to many other studies.  CRP is an acute phase protein produced in
the liver and is a marker of the inflammatory cascade97.  Thus,  many studies have been
undertaken investigating the association of this protein with cardiovascular diseases.  In
accordance with the overwhelming evidence pointing to inflammation as a mediator of CVD, the
vast majority of the studies examining cardiovascular events have shown a great association
between this protein and CVD98,99,100.  As mentioned previously, the association between CRP
and cardiovascular events decline with age.  However, several studies involving young men and
women have shown baseline CRP to be predictive of future cardiovascular anomalies and CVD
related mortality101,102.  This positive correlation between CRP and CV events is not surprising as
it is primarily released in response to IL-6, which has been stated to have a positive association
with CVD.
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Inflammation and atherosclerosis
Evidence suggests inflammation plays a fundamental role in the onset and progression of
atherosclerosis97.  According to Glass103, atherosclerosis can be considered a form of chronic
inflammation resulting from the lipoproteins, macrophages, T-cells, and the cellular elements of
the arterial wall. Signs that an inflammatory response factors in the earliest stages of the disease
can be seen in mice shortly after being fed an atherogenic diet97. At this stage, lipids begin to
accumulate within the arterial wall causing the endothelium to express selectins and intracellular
adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1(VCAM-1). These molecules
attract and bind circulating monocytes to the cell wall104,105,.  Whether or not these molecules play
a role in atherogenesis were put to rest upon seeing apoE deficient mice missing genes for both
E- and P- selectins.  Deletion of these genes resulted in a 40-60% decrease in atherosclerosis106.
Collins et al.107 yielded similar results with the deletion of the ICAM-1 gene.
After adhering to the endothelial surface, monocytes gain entry into the arterial wall by
exposure to oxidized LDL108.  Oxidized LDL can not only attract these cells directly, they can
also induce endothelial cells to release MCP-1109. Further evidence of this is seen with the
expression of CCR-2 (MCP-1 receptor) on monocytes, which is positively influenced by
cholesterol levels.  Han et al.110 substantiates this by showing increased chemotaxis to MCP-1 in
hypercholesteremic patients.  Alternatively, elimination of the CCR-2 gene reduces the
development of atherosclerosis in apoE deficient mice111.
Upon migrating in the subendothelial space, monocytes differentiate into macrophages.
After which, oxidized LDL are taken in to the macrophage via scavenger receptors such as SR-A
and CD-36112.  Removal of these receptors reveals their importance in atherogenesis, as without
them, apoE mice exhibit greatly reduced levels of atherosclerosis113.
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 Oxidized LDL engulfed by macrophages have several fates, one of them being stored in
lipid droplets characteristic of foam cells97.   Cholesterol in the droplets can be disposed by the
macrophages.  This is primarily done by “reverse cholesterol transport” via HDL.  However, if
the level of accumulation is greater than what can be eliminated, foam cells continue leading to
fatty streaks.
Inflammation again plays a role in the progression of fatty streaks to more complex
lesions.  Complex lesions are distinguished by the migration of smooth muscle cells from medial
layer to the intimal or subendothelial space103.  Smooth muscle cells may proliferate and add to
foam cell load by taking in oxidized LDL.  At this point, a fibrous cap may form.  This cap
consists of smooth muscles in a collagen-proteoglycan mixture114.  This phase is considered
inflammatory as T-cells (glass), macrophages , and smooth muscle103 have been obtained from
lesions115.  Furthermore, there is evidence indicating these cells as being activated116.
Atherosclerosis and fibrous cap progression can lead to plaques containing small or
absent necrotic lipid cores and a thick fibrocalcific core115.  Evidence exists indicating this thick
calcified cap may actually be protective.  Hunt et al.117 illustrated that coronary artery patients
with calcified plaques experienced less symptoms of stroke and ischemic attacks when compared
with those without calcification.  However, plaques with this type of cap have been associated
with severe narrowing of arteries114.
In stark contrast to the thick calcified cap, lesions may develop into plaques containing a
large necrotic core and a thin fibrous cap.  Lesions of this sort are more vulnerable to rupture and
have been frequently observed in patents succumbing to acute myocardial infarction114.
Interestingly, these types of caps contain large amounts of macrophages, T-lymphocytes and
other inflammatory products115,118
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There is clear indication that inflammation plays an integral role in the development and
progression of atherosclerosis.  Therefore, efforts to reduce inflammation -or the products and
processes that induce it - should be investigated in greater detail.
Epicardial Fat, Obesity, and Disease
As mentioned above, visceral fat has been shown to be more inflammatory than
subcutaneous adipose tissue.  Visceral fat has also been more closely associated with diseases
such as Type II diabetes and cardiovascular disease.  Due to these findings, principally the later,
scientists began examining a type of visceral fat very specific to the heart –epicardial fat.
Epicardial fat is a visceral fat deposit found on the heart119.  Unfortunately, studies on this tissue
are sparse and have only recently begun to compile. With that said, observations between
correlating epicardial fat and obesity have been documented since the beginning of the 20th
century.  In 1933, Smith and Willius120 noticed that epicardial deposits increased with obesity in
obese cadavers.  Epicardial fat is commonly deposited along the interventricular and
atrioventricular grooves121.  However, in some cases the entire heart may be completely covered
in a layer of epicardial fat103.  The close proximity of epicardial fat to the coronary arteries, the
fact that nothing separates it from the myocardium119 , in conjunction with its  proinflammatory
nature122,123, has compelled researchers to further investigate this tissue.
Though having a heart completely covered in epicardial fat is an extreme case, epicardial
adipose thickness has been correlated with the severity of coronary artery disease.  Utilizing over
two hundred patients with coronary artery disease, Iacobellis et al.124 were examined to see
whether a relationship between epicardial fat and coronary artery disease severity could be
established.  Subjects underwent a coronary angiography in order to assess the severity of their
atherosclerotic lesions.  Electrocardiograms performed in order to determine epicardial fat
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thickness on the free wall of the right ventricle.  The area of the right ventricle is assessed
because this is the portion of the heart that increases in adiposity initially.  Thickness over the
left ventricle and between the apex and base occurs much later124.  The researchers also
compared epicardial fat thickness with other risk factors and coronary atherosclerosis.  Results of
the study revealed significant correlations between epicardial adipose tissue thickness and age,
C-reactive protein (a global marker of inflammation), body mass index, and waist circumference.
The study also showed epicardial adipose tissue thickness as an independent factor affecting
coronary artery stenosis.
 In another study, Iacobellis et al125 investigated the relationship between epicardial
adipose tissue to cardiac, metabolic, and anthropometric markers of metabolic syndrome.
Participants, whose morphology ranged from lean to obese, had their right ventricle imaged and
analyzed for epicardial fat thickness via echocardiogram. Cardiac, metabolic, and anthropometric
measures were also taken. Their results showed a very high correlation between epicardial fat
deposition and magnetic resonance imaging of visceral adipose tissue.  The results also revealed
that waist circumference and diastolic blood pressure (both independent risk factors for coronary
artery disease) were strongly correlated with epicardial adipose tissue thickness.
Most methods analyzing epicardial fat and its relation to CVD has been indirect.  As seen
above, most studies have utilized echocardiograms to assess epicardial fat deposition.  However,
there are a few projects that have utilized a more direct method of analysis.  Employing
epicardial tissue biopsies obtained from patients undergoing open-heart procedures Cheng et
al.122 revealed TNFα, IL-6, leptin, and visfatin are of greater concentration in epicardial adipose
tissue from patients with CAD.  Moreover, significant decreases in adiponectin were also seen in
this tissue from patients undergoing bypass surgery.
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Another method in which epicardial adipose tissue can be associated to atherosclerosis is
by seeing how the disease progresses devoid of the adipose depot.  In order to do this, some
scientists have looked at how a myocardial bridge affects coronary atherosclerosis.  Myocardial
bridge is a common anatomical condition in which the left anterior descending coronary artery is
covered by myocardial tissue instead of epicardial adipose tissue126.
A study performed by Ishikawa et al.127 tested whether the myocardial bridge protected an
artery from developing atherosclerosis.  Their study utilized white rabbits as a model of
atherosclerosis.   These rabbits were fed a diet high in cholesterol for 20 weeks, after which, they
were sacrificed.  Two segments of their left coronary arteries were assessed for the presence of
atherosclerotic lesions.  One segment of the artery ran through epicardial adipose tissue while the
other segment entered the myocardium and had no contact with the adipose depot.  Their results
revealed that segments surrounded by epicardial fat had developed atherosclerotic lesion while
the other did not.
The mechanism proposed by which the myocardial bridge may prevent atherosclerotic
lesion formation may be due to a change in homodynamic forces.  Low shear stress may aid in
the formation of atherosclerotic lesions by allowing a greater amount of lipids to enter the
vascular wall126.  Studies have indicated that the shape and pattern of the epithelial cells may
influence the amount of shear stress the vessel is exposed to.  Studies in rabbits and rats128 reveal
spindle-shaped endothelial cells lining the portion of the descending coronary artery within the
myocardial bridge.  As expected these portions had a greater amount shear stress compared to the
portion exposed to epicardial adipose tissue.  Additionally, this portion of the artery consisted of
polygonal shaped endothelial cells.  In humans, the portion of the descending coronary artery
proximal to the myocardial bridge contain endothelial cells are flat and arranged in a pave-like
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pattern thus allowing for high shear stress, much higher than the portion of the vasculature
exposed to epicardial adipose tissue129.  In both of these examples, the areas of high-shear stress
were free of atherosclerotic lesions, whereas the portion exposed to low shear stress and
epicardial adipose tissue exhibited signs of lesions.
Adventitial Adipose Tissue and Its Role in Atherosclerosis
It has been shown that atherogenesis results from the transendothelial passage of
cholesterol-rich Apo-B lipoproteins from plasma into the intima.  Inside the vasculature, these
lipids are oxidized, and in conjunction with a chronic inflammatory response within the vessel
layers, plaque formation can ensue126,130.  Due to the proinflammatory nature of epicardial
adipose tissue and its close proximity to the coronary arteries, it has been identified as one of the
possible contributors to the formation of atherosclerotic lesions.  Using this same rationale,
scientists have begun to look at another adipose depot as a possible risk factor for
atherosclerosis.  That depot is adventitial adipose tissue.
Adventitial adipose tissue is classically considered the outermost connective tissue of a
vessel131.  Adventitial fat has been generally ignored in the study of atherosclerosis132. This is
unfortunate because all the vessels associated with atherosclerotic lesions possess it.
Just as information on epicardial fat is minute, very few studies have been performed on
adventitial fat.  Of the few, Mazurek et al.66, compared levels of MCP-1 mRNA and other
inflammatory cytokine levels in adventitial adipose tissue from the right coronary arteries and
subcutaneous adipose tissue in patients undergoing coronary artery bypass surgery.  The results
of the study revealed that adventitial fat expressed these inflammatory cytokines at significantly
higher levels than subcutaneous fat.  Unfortunately, this result was not correlated with lesion
formation.
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In another study, Tavora et al.133, addressed the role of adventitial in atherosclerosis.
Their study aimed to correlate the degree of adventitial inflammation in epicardial arteries with
the underlying intimal atherosclerotic plaque.  The researchers studied sections of coronary
arteries from patients that died of coronary artery disease and assessed the adventitial adipose
tissue associated with the plaques and segments.  The results revealed that adventitial
lymphocytic inflammation increased with stenosis.  It also indicated that hemorrhage into late
core, rupture, erosion, and thin caps had greater adventitial inflammation independent of stenosis
severity.  Lastly, adventitial adipose macrophage density was increased in plaques with
atheromas and positively correlated with adventitial lymphocytes and macrophage content.  The
authors concluded that features associated with plaque instability are associated with adventitial
adipose tissue inflammation.
Though these were the only two studies that specifically addressed the possible function
of adventitial adipose tissue in the onset or progression of atherosclerosis, this combined with
our knowledge about adipose tissue, especially epicardial adipose tissue, begs us to further
investigate the role adventitial adiposity
Mechanism by Which Epicardial Fat Influences Atherosclerosis
Unfortunately, the mechanism by which epicardial adipose tissue directly mediates
atherosclerosis remains elusive.  This fat deposit has been associated with changes in cardiac
morphology, such as increased left ventricular hypertrophy.  Excess weight placed on the
ventricles due to fat deposition increases the effort needed to pump blood inducing, thus
inducing hypertrophy.  In fact, left ventricular hypertrophy has been positively correlated with
left epicardial mass in several studies134,135.
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Regrettably, this alteration in morphology has not been implicated in the development of
atherosclerosis.  Thereby, the most obvious perpetrators are the inflammatory products produced
in and by epicardial fat.  As mentioned, no fascia separates epicardial fat and the myocardium.
For these reasons, Glass103 proposed a hypothetical mechanism for how inflammatory products
originating from epicardial fat may mediate the development of atherosclerosis.  This
hypothetical mechanism involves paracrine and vasocrine signaling to shuttle inflammatory
mediators into the intima.  For the pathway involving paracrine signaling, Glass states that
adipokines produced by adipocytes and stromal-vascular cells in epicardial fat diffuse in
interstitial fluid and travel across the adventitia, media, and into the intima.  There, they interact
with all components of plaque formation.  In contrast, vasocrine involves inflammatory products
entering the vaso vasorum where they travel across the vessel into the lumen.  They are shuttled
downstream to interact with the lesion as well as all the cells in both the intima.  Interestingly,
this model allows for macrophages and lymphocytes to migrate to the intima along the vasa
vasorum via openings in the media.
Heart Triglyceride Level and Its Relation to Epicardial Fat.
Studies investigating epicardial deposition have primarily used echocardiograms to
determine and quantify changes in this tissue9,10,136.  These studies utilize humans as subject and
the epicardial fat pad in obese is fairly easy to image.  Conversely, our subjects are mice whose
fat pads are often times often barely visible to the human eye.  Therefore, we have to employ a
method in determining epicardial fat content.   We accomplished this by determining the
concentration of myocardial triglyceride content.  This is very similar to the manner by which the
level of hepatic steatosis (fatty liver) is ascertained.  To our knowledge, this method of
determining epicardial fat deposition has not been performed before.  However, there is reason to
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believe this may be a valid technique.  In a study investigating the relationship between
myocardial triglycerides, epicardial fat, and heart function Kankaanpaa et al137, found a strong
positive relationship between heart triglycerides and epicardial fat in obese men.  The cause for
this, they claim, is similar to the development of hepatic steatosis, in that the liver is the first-pass
organ that free fatty acids from an adipose depot (intra-abdominal fat) deposit into.   Similar to
this, the epicardial fat deposits free fatty acids into the myocardium.  Furthermore evidence
suggests that this mechanism appear to be similar in both obese humans and animals138,139.
Exercise Decreases Adipose Tissue Inflammation
There are several studies that that have been performed to assess the effects of physical
activity on inflammation140,141.  These studies often measure the expression of CRP, an acute
phase protein released by the liver142 and considered one of the best markers of inflammation.
These studies all indicate that the average CRP levels in the subjects that performed the most
physical activity was still markedly lower than in the subjects that performed the least physical
activity143,144.
Utilizing male patients with chronic heart failure study, Adamopoulos et al. 145, looked at
whether exercise could affect markers of inflammation.  After participating in a 12-week
exercise program, these patients showed a significant reduction in MCP-1 and other
proinflammatory markers.
Indicating that these results will apply to women,  Okita et al.146 placed healthy women in
an exercise intervention for two months after which CRP levels were assessed.  The results
showed that the greatest significant declines in CRP were in those that lost a moderate amount of
weight.  Those that lost the most weight did not have significantly lower levels of CRP, although
downward trend was seen.  The researchers suggested that strenuous exercise might have
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negative effects in those that did not show a significant decrease in CRP.  This study also showed
the possibility that weight reduction may be an independent factor in the reduction of
inflammation.
The vast majority of these studies measured changes in subcutaneous or epididymal
adipose tissue with respect to exercise.  However, there is one study that examines the effect of
exercise in epicardial adipose tissue.  Kim et al.9 assessed how a 12-week exercise program
affected markers of insulin resistance, epicardial thickness, and CRP levels among others.  The
results indicated that exercise aerobic exercise significantly reduced epicardial thickness.  It also
revealed that an acute bout of aerobic exercise could improve markers of insulin resistance.
Unfortunately, the exercise program did not reduce CRP levels.  The main problem with this
study was the fact that there was no control group.  Since the subjects lost an average of 3kg, the
decrease in epicardial adipose tissue may have stemmed from weight loss instead of exercise.
This would follow in line with the finding in the previous study discussed.
Lastly, our lab produced a pilot study investigating intradialytic exercise and its effect on
epicardial fat thickness10.  Data from this study indicated a significant reduction in epicardial fat
in those that participated in the exercise intervention.  This and the result from the previous study
suggest the ability of exercise to mediate epicardial fat deposition.
Potential Mechanism Behind the Anti-Inflammatory Effect of Exercise
Reduction of Macrophage Infiltration
The role of macrophages in the inflammatory response has been established. Evidence
has shown that macrophages accumulate in obese adipose tissue80.  Studies have also shown that
these the inflammation associated with obesity stems from macrophages occupying the non-
adipocyte portion of adipose tissue147.  This macrophage population has been shown to correlate
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with increased adiposity and adipocyte size.  As mentioned in some of the studies discussed
earlier, macrophages release MCP-1, a cytokine that attracts monocytes to the cause of the
inflammatory response.  Exercise has been shown to decrease MCP-1 in people suffering from
metabolic syndrome148.  Therefore, by decreasing levels of MCP-1, exercise may be a powerful
factor in decreasing inflammation in adipose tissue by reducing macrophage infiltration.
The Cholinergic Anti-Inflammatory Pathway
Tracey and Pavlov149 coined the term “cholinergic anti-inflammatory pathway”.  These
researchers state that the stimulation of the vagus nerve inhibits proinflammatory cytokines from
being released.  They suggest that the autonomic nervous system induces the inflammatory
response through the release of glucocorticcoids.  The body then counters this through the vagus
nerve or parasympathetic nervous system release of acetocholine, which prevents the release of
proinflammatory cytokines.  This may be entirely possible as exercise has been shown to
increase vagal tone.  This stimulation of the vagus nerve may cause the release of acetocholine
and thus promote an anti-inflammatory response.  This may be extremely important in mediating
atherosclerosis progression as the vagus nerve infiltrates the adventitia of coronary arteries and
aorta.
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CHAPTER 3: METHODS
Animals and Diet
Four-week-old male C57/Bl mice (n=73) were purchased from Jackson Laboratories (Bar
Harbor, Me) at 4 weeks of age.  After acclimatization of 1 week, all animals were individually
caged and fed a 45% fat diet (high fat diet) to induce obesity.  These animals were then assigned
to:  high-fat sedentary, high-fat exercise, low-fat sedentary (10% fat diet), or low-fat exercise for
12 weeks. Animal feed was obtained from Research Diets Inc. (New Brunswick, NJ); specific
information regarding diet can be found in Table 1.  All animals were allowed to eat ad libitum
and both food intake and body weight were recorded twice a week for the extent of the study.
Animals were housed on a reverse light-dark cycle (lights on at 21:00 h and off at 09:00 h) at 25°
C.  The diets are well tolerated by the animals and both diet and the duration of the intervention
is a well-accepted model for diet-induced obesity.  All experiments were approved by the
Institutional Animal Care and Use Committee and supervised by the Division of Animal
Resources at the University of Illinois at Urbana-Champaign.  Guidelines followed for the care
and usage of the animals were directed by the National Institute of Health.
Exercise Training Intervention
Animals (in the exercise group) were exercised on a motorized treadmill (Jog-A-Dog,
Ottawa Lake, MI) during their dark cycle.  Negative reinforcement such as electric shock was
not used, as they were not deemed necessary.  As a substitute, a foam pad was placed at the back
of each lane in order to serve as tactile response.  Another purpose of the pad was to prevent the
animal’s tail from being pinched between the treadmill and the back of the lane.  Mice were
exercised for a duration of 40 minutes at a speed of 12 m/min at 5% grade for 5 days a week.
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For acclimatization, the mice began exercising for 20 minutes per day.  The duration was
increased by 2 minutes each subsequent day until 40 minutes was attained.
Heart and Liver Triglycerides
Animals were sacrificed by cervical dislocation and both hearts and livers were perfused
with PBS and removed from the animals.  The organs were then sliced in half and the bottom
portion is what is utilized for this assay.  Each portion was weighed and placed in 4 ml of
isopropanol.  Tissues were then homogenized for 7-10 minutes in the isopropanol using a
motorized hand homogenizer (PowerGen 125, Fisher Scientific).  The homogenate was
centrifuged at 2,000 g for 10 minutes, after which the liquid was collected.  Triglyceride content
in the isopropanol solution was measured using a commercially available triglyceride assay kit
(Wako Diagnostics, Richmond VA).  Triglyceride content was corrected for sample weight.
Statistics
Both myocardial and liver triglyceride content were analyzed using a 1-way analysis of
variance (ANOVA).  For diet and weight measures, repeated measure ANOVAs (diet x time)
were conducted.  Post-hoc Tukey HSD comparisons were used to determine group differences
and < .05 was accepted as statistically significant.  SPSS version 16.0 (Chicago, Il.) was utilized
for all analyses.
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CHAPTER 4:  RESULTS
Body weight.
Fig. 1 illustrates the changes in body weight brought about by the intervention.  At the
pre-intervention time point, which was preceded by 6 weeks of high-fat feeding, these diet-
induced mice showed significantly higher body weights than animals solely fed a CHOW diet
(p<.001).  Significant differences can also be seen at the 4, 8, and 12 week time points in all
groups (p<.05) except for the low-fat sedentary and low-fat exercise groups.   All groups gained
weight throughout the intervention indicating a time effect (p<.001).  In addition, significant time
x exercise (p<.001) and time x diet (p<.001) interactions were also present.
Hepatic steatosis.
Triglyceride levels within the liver are noted in Fig. 2.  Using a one-way ANOVA, our
results indicate a significant difference between the groups (p < 0.001).  Both exercise groups
(HF-EX and LF-EX) had significantly less triglyceride content to their sedentary counterparts (p
< 0.001 for both).  Surprisingly, diet did not have a significant effect on hepatic triglyceride
levels.  Comparison of HF-EX and HF-SED as well as LF-EX and LF-SED, produced no
significant differences.
Heart triglycerides.
After performing ANOVA on data obtained from triglyceride assays performed on heart
tissue, we found significant differences between groups (p < 0.001).  Tukey post hoc
comparisons of the groups indicated that exercise has a significant effect on animals on a high-
fat diet (p < 0.001).  However, exercise did not produce a significant change in triglyceride
content in animals given a low-fat diet (p=.089).  Diet produced significant changes in heart
triglyceride levels in both exercise and sedentary animals.  Myocardial triglyceride content in
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these animals was significantly larger in high-fat animals compared to low-fat fed animals in
both exercise and sedentary groups (p < 0.01 for both).
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Table 1.  Diet Composition.
HFD LFD
gm% kcal% gm% kcal%
protein 24 20 19.2 20
CHO 41 35 67.3 70
fat 24 45 4.3 10
kcal/gm 4.73 3.85
gm kcal gm kcal
sucrose 172.8 691 350 1400
soybean
oil 25 225 25 225
lard 177.5 1598 20 180
total 858.15 4057 1055.05 4057
Rodent diets D12450B and D12451; Research Diets, Inc. (New Brunswick, NJ)
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Figure 1 shows the progression of body weight from pre-intervention and 4, 8, 12 week time
periods.
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Figure 2 illustrates liver triglyceride content.  Exercise produced significant changes in
triglyceride content in both high fat and low-fat fed groups (p=.000, .000).  Diet produced no
significant differences
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Figure 3 shows myocardial triglyceride levels.  Low-fat diet produced significant effects on both
sedentary and exercise groups (p=.002, .000). Exercise only produced a significant effect on
animals fed a high-fat diet (p=.005).
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CHAPTER 5:  DISCUSSION
The primary finding in this study was that both exercise training and dietary fat
composition can have significant effects on visceral fat accumulation on both heart and liver.  In
addition, our data also points to the ability of exercise and a low-fat diet to attenuate total body
weight gain.  With respect to triglyceride accumulation, diet attenuated increases in the
myocardial tissue in both high fat and low fat groups.  Exercise, however, only produced a
significant change in animals fed a high fat diet.  This can be explained by the small increase in
triglyceride levels produced by the low fat diet when compared with that incurred by the animals
fed a high fat diet.  Exercise interventions have been shown to produce greater results in subjects
with greater levels of adiposity.  With regard to hepatic steatosis, exercise significantly
attenuated triglyceride accumulation in both high fat and low fat groups.  Unfortunately, a low-
fat diet did not produce a significant effect in hepatic triglyceride levels.  This result parallels
that found by Viera et al.12 who utilized similar interventions and animals.  While this result
seems counterintuitive, the amount of sucrose (70%) in the low fat diet is similar to amount used
in some high-carbohydrate diets which have often result in increased hepatic steatosis167.
Though much more knowledge needs to be attained, these findings imply exercise may be the
more effective than a low-fat diet in reducing epicardial fat.
Increased adiposity is a well-established risk factor for cardiovascular diseases such as
atherosclerosis150 .  Unfortunately, the mechanisms that connect adiposity and cardiovascular
anomalies are controversial and not fully understood.
Though escalation in total body adiposity is of great concern, much evidence suggests visceral
fat (rather than subcutaneous fat) plays an important role player in the development of
cardiovascular abnormalities11,151,152.  As a result, techniques such as weight reduction therapy,
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drugs, and other methods153 to reduce visceral fat has become a primary research focus.  This
shift in attention has proved fruitful as weight loss therapies, such as caloric restriction and the
manipulation of macronutrients, have been revealed as an effective method of reducing visceral
fat154,155,156,157.  Exercise also has been shown to have an effect on visceral fat.  In fact, Viera et
al.12  has recently produced results indicating exercise has the ability to reduce epididymal fat.
With intra-abdominal adipose tissue garnering most of the attention, cardiac adiposity
and its effect on cardiac disease has only recently been studied119. Epicardial adipose tissue is a
layer of visceral fat surrounding the heart. In conjunction with its proximity to the coronary
vessels, the inflammatory nature of this tissue has led to speculation that epicardial fat may play
a role in the development of cardiovascular disease66,103.  As a result, studies have revealed this
tissue’s association with impaired cardiac function, cardiovascular risk, and visceral fat
deposition153. Unfortunately, little work has been done investigating methods that can reduce
epicardial fat deposition.
 To the best of our knowledge, our study is only one of three that have investigated the
effect exercise can have on epicardial fat deposition, and is the first to perform it on animals.
The first study to look at how exercise affects epicardial fat thickness was performed by Kim et
al9.  Their results indicated that a 12-week intervention of running at a moderate intensity
decreases epicardial thickness by 8.6%.  Unfortunately, a limitation of their study was a lack of a
non-exercising control group.   Wilund et al.10 undertook the only other study of looking at this
relationship.  In a pilot study, patients on maintenance hemodialysis therapy underwent
intradialytic exercise for 4 months.  These patients, using a cycle ergometer, exercised for 45
minutes at a moderate intensity during their scheduled dialysis session.  The findings were
similar to the previous study with a reduction in epicardial fat thickness of 9.8% in the exercise
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group, with no change in the control group.  Our data produced results that seem to parallel those
of the studies above.  Epicardial fat, in this study was more dependent on exercise and weight
than diet.  Weight having an effect on epicardial fat is not surprising as there is evidence that
indicates epicardial fat can be reduced through weight loss.  Iacobellis et al.158 revealed a 4 mm
decrease in epicardial fat thickness in obese participants that lost weight after undergoing a 6-
month low calorie diet intervention.  Similar results were found in patients that lost weight after
bariatric surgery159.
Unfortunately, there have been no randomized-controlled studies performed relating
epicardial fat and diets with different macronutrient content.  As mentioned before, epicardial fat
is considered a form of visceral fat.  Therefore, we can only surmise their relationship based on
how visceral fat deposits are affected by these diets.  If we relate epicardial fat to visceral fat,
then this result is very similar to that found by Viera et al.12.  Using a very similar diet and
exercise intervention, these researchers undertook a study that revealed epididymal fat pad
growth was significantly attenuated in animals that consumed a low-fat diet. This present study
revealed animals that have undergone a low-fat diet did not have significantly lower levels of
heart triglycerides/epicardial fat than those on a high-fat diet.   In addition, and similar to our
result, these low-fat fed mice weighed significantly less than the mice fed a high-fat diet12.
These results indicate that diet and weight are more important than exercise in the attenuation of
epicardial fat deposition.  Unfortunately, these results are in opposition of the other epicardial fat
studies mentioned above, whose results point to exercise being the more effective method in
managing epicardial fat accumulation.
Our results clearly elucidate the need for further investigations on how exercise affects
epicardial fat deposition.  As stated, this study is only one of three that has been undertaken
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relating epicardial fat and exercise, and our results oppose their findings regarding the matter.
However, our result concerning weight and diet-type does parallel several studies indicating their
ability to reduce and prevent the accumulation of epicardial fat and other visceral adipose tissue
deposits.
Limitations
Our study utilized treadmill running as the mode of exercise.  When compared to
volunteer wheel running, the drawback to this mode of exercise is the stress inflicted on the
animals by forcing them to run.  However, our study did not employ electric shocks, nor did we
prod the animals to run.  In order to encourage our animals to run, we placed a foam pad at the
end of their lanes.  This provided a physical sensation that persuaded them to run.  Volunteer
wheel running has its drawbacks as well.  Some animals may run extreme distances, distances
that most humans would not be able to incur on a daily basis.  Alternatively, aged mice perform
little voluntary wheel activity. Though volunteer wheel running may provide less stress to the
animals, this method may yield inconsistent results, as the amount of running time for each
mouse can be highly variable160.  We feel treadmill running, using our method of encouragement,
causes minimal stress to the animals.  In addition, treadmill running is a way we can control the
amount of activity consistent and applicable to the public health recommendations.
Another limitation to our study is the method by which we measure epicardial fat.  Our
study used heart triglyceride levels to approximate epicardial fat levels.  We decided on using
this technique due to the difficulty in measuring epicardial fat pads using echocardiography.
However, we are confident in our choice due to a finding by Kankaanpaa 137, that myocardial
triglyceride levels are positively correlated with epicardial fat mass.  Though their study was
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performed on humans, our methods/findings should still be applicable as there is evidence
indicating both animals and humans share similar mechanisms in myocardial triglyceride influx.
 Though our study shows exercise can reduce epicardial fat we must disclose that the type
of mice used for this study may not be the best model for epicardial fat accumulation.  The
animals used in this project (C57/Bl6) are one of the most widely used inbred mouse strains used
for models of disease.  Our decision for using this strain came from observations we made during
dissections of mice used in other projects.  We noticed that aortic adventitial adipose tissue in
high-fat fed sedentary obese mice compared with their lean or exercised counterparts.  This
observation prompted us to undertake this project using this particular mice model.  Regrettably,
this strain had very little, if any, epicardial fat deposition evident.  This coincides with Sack’s161
suggestion that future animal studies (investigating epicardial fat) be performed on pigs, rabbits,
and monkeys, animals with discernible epicardial adipose tissue.
Future studies
Studies investigating the relationship between epicardial fat and cardiovascular disease
are sparse.  Adding exercise as a variable reduces the number dramatically.  Though exercise has
been shown to help reduce epicardial fat mass, physical activity has not been shown to affect
inflammation levels in this particular tissue.  As mentioned above, exercise can reduce
inflammation in visceral fat.  As epicardial fat is a form of visceral adipose tissue, exercise may
have similar effects on its inflammatory profile. Furthermore, with the vagus nerve having
terminations in within the adventitia of coronary arteries, it is conceivable that exercise may have
an anti-inflammatory effect via the cholinergic anti-inflammatory complex.  Thus, future
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investigation of whether exercise can reduce epicardial fat inflammation is warranted.  In
particular, consideration should be made on the effect of exercise on macrophage infiltration.  As
mentioned, visceral fat is more inflammatory and has a greater association with inflammatory
diseases than subcutaneous fat.  Interestingly, macrophage infiltration in obese individuals has
been shown to be greater in visceral fat when compared to subcutaneous adipose tissue79.
Macrophages have been have been implicated in playing a role in diseases such as diabetes.
Modification of the MCP-1 gene in mice and its receptor has led to improvements in insulin
resistance162,163.  As for cardiovascular disease, macrophages are present in virtually every stage
of atherosclerosis, and are integral in the formation of foam cells.  Macrophages have also been
found in epicardial fat associated with cardiac events.  Recently, exercise has been revealed to
reduce MCP-1 in visceral adipose tissue164.  Therefore, it would of interest to investigate whether
exercise would attenuate macrophage infiltration in epicardial adipose tissue.
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CHAPTER 6:  CONCLUSION
The prevalence of obesity is staggering.  In order to describe the magnitude of how many
suffer from this disease, many have used the term “epidemic”.  However, this doesn’t accurately
describe the scale of how pervasive this disease has become.   For quite some time, excess
adiposity and increased weight gain have been an issue in a few select countries--the United
States being one of them. This is beginning to change as reports have shown a massive and rapid
increase in obesity rates across the globe.   Thus, the word “epidemic” can no longer suffice and
should be substituted by the more appropriate term “pandemic”.  This disease has crossed oceans
and continents.  And, as frightening as this may be, a new “border” has been breached by this
disease, that “barrier” is age.  For quite some time, weight gain and obesity has been thought to
primarily affect adults, as it is true that increases in adiposity usually comes with age.
Unfortunately, research has indicated that the incidence of childhood obesity is rising at an
incredible rate.  Data from these studies tell us that the pervasiveness of childhood obesity has
more than doubled in the last twenty years, and that it continues to rise in an accelerated rate.
As the prevalence of obesity continues to rapidly increase, concern with its co morbidities
becomes of utmost importance.  Diabetes, certain types of cancer, Alzheimer’s disease, and
depression have all been linked to obesity.  In addition, cardiovascular disease, the number one
cause of death worldwide, has been closely linked to obesity.  Cardiovascular disease is
considered an inflammatory disease, and inflammation is the link between this disorder and
obesity.  Pro-inflammatory markers such as: TNF-α, Il-6, MCP-1, VCAM, CRP, t-cells, and
macrophages rise with increased adiposity and have all been positively associated with
cardiovascular disease.  In fact, these and other pro-inflammatory proteins are present in every
stage of and may help mediate the progression of atherosclerosis.
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Though previously thought of as an inert storage depot, much work has been done to
redefine adipose tissue as an extremely active tissue capable of aiding in the inflammatory
response by producing inflammatory cytokines and recruiting agents critical to the response.  In
addition, research has shown that of the two major types of adipose tissue (visceral and
subcutaneous), visceral fat is considered much more metabolically active and closely associated
with inflammation and cardiovascular disease.
Due to the inflammatory nature of visceral fat and because of its proximity to the
coronary arteries, epicardial fat has garnered much attention from scientists in recent years.
Epicardial adipose tissue, which is considered a true form visceral fat, has been shown to become
increasingly inflammatory as adiposity increases, similar to the more traditional depots of
visceral fat.  Because there is no visible fascia or barrier that separates this tissue from the
coronary arteries, epicardial fat has been thought to supply macrophages and other inflammatory
products to the intima via paracrine and vasocrine signaling.   There they interact with all the
components of plaque formation to mediate the progression of atherosclerosis.  Though not much
work has been performed on epicardial fat (in comparison to visceral fat depots in organs located
in the abdomen), there is indication that epicardial is positively associated with atherosclerosis.
Obesity and its co morbidities have placed an enormous emotional, physical, and
monetary burden on our society.  Therefore, much effort has been spent trying to find a way to
curtail the spread of these disorders.  Two of the major causes for this rapid increase in obesity
have been due to our increasingly sedentary nature and the rise in caloric intake, especially due
to the abundance of high-fat food sources.  With this in mind, exercise and a low-fats diet have
been prescribed as a method by which adiposity can be attenuated.  Both of these techniques
have proven effective as indicated by our colleagues’ results as both epididymal fat pads were
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significantly reduced.  Unfortunately, not much work has been performed on the effect of
exercise and diet on epicardial fat deposition.   As of this time, only two studies have been
performed on epicardial fat and exercise, and our lab undertook one of them.  Results from these
studies reveal that epicardial fat can be reduced by exercise.  This present study parallels those
findings.  In addition, our results also state that consuming a low fat diet can also reduce
epicardial fat deposition.
Though there is evidence linking epicardial fat deposition to disease severity, much more
work has to be done in solidifying this association.  Future studies can focus on macrophage
accumulation in epicardial fat.  Macrophages are extremely important in the progression of
atherosclerosis.  Macrophages have been associated with insulin resistance and cardiovascular
disease.  These phagocytic cells have also been reported in every stage of atherosclerosis, and are
a major factor in the creation of foam cells.  It has also been shown that macrophage infiltration
in epicardial fat is positively correlated with adiposity.  Thus, as exercise has been shown to
decrease epicardial fat deposition, a project investigating whether exercise reduces macrophage
infiltration is justified.  Interestingly, exercise may also have anti-inflammatory properties.  The
“cholinergic anti-inflammatory pathway” is a method by which the body counteracts the
inflammatory response.  Stimulation of the vagus nerve induces the release of acetocholine,
which inhibits the release of pro-inflammatory cytokines.  Exercise has been shown to increase
vagal tone, thereby leading to the issue of whether it has an effect on macrophage infiltration in
epicardial fat.
 In conclusion, both exercise and a low fat diet provide for effective treatments in
reducing epicardial fat deposition.  This may be one of the mechanisms by which it helps reduce
the risk of cardiac events.  More research still has to be undertaken in order to further understand
43
these processes.  Lastly, both exercise and low-fat serve as valuable treatment options for
attenuating weight gain or reducing obesity.
44
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